.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Chubb
Covington
AstraZeneca
McKinsey
Boehringer Ingelheim
Moodys
Dow
Harvard Business School
UBS

Generated: December 13, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 014715

« Back to Dashboard

NDA 014715 describes TRIAVIL 4-50, which is a drug marketed by New River and is included in one NDA. Additional details are available on the TRIAVIL 4-50 profile page.

The generic ingredient in TRIAVIL 4-50 is amitriptyline hydrochloride; perphenazine. There are thirteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amitriptyline hydrochloride; perphenazine profile page.

Summary for 014715

Tradename:5
Applicant:1
Ingredient:1
Patents:0
Formulation / Manufacturing:see details

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength25MG;2MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength10MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Summary for product number 004

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength10MG;2MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Expired Orange Book Patents for NDA: 014715

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
New RiverTRIAVIL 2-25amitriptyline hydrochloride; perphenazineTABLET;ORAL014715-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
New RiverTRIAVIL 4-50amitriptyline hydrochloride; perphenazineTABLET;ORAL014715-006Approved Prior to Jan 1, 1982► Subscribe► Subscribe
New RiverTRIAVIL 4-25amitriptyline hydrochloride; perphenazineTABLET;ORAL014715-005Approved Prior to Jan 1, 1982► Subscribe► Subscribe
New RiverTRIAVIL 4-10amitriptyline hydrochloride; perphenazineTABLET;ORAL014715-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Federal Trade Commission
US Army
UBS
Fuji
Julphar
Citi
Novartis
Cantor Fitzgerald
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot